ELVN Stock-Based Compensation
Enliven Therapeutics Inc · Stock-Based Compensation
ELVN Stock-Based Compensation
Latest reported$40.81Mperiod ending
ELVN Stock-Based Comp ($0.00 → $40.81M)
Annual stock-based compensation
High-resolution chart · PNG
ELVN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 34,019,000 | |
| 20,174,000 | |
| 12,914,000 | |
| 3,191,000 | |
| 1,924,000 | |
| 130,000 | |
| 899,000 | |
| 555,000 | |
| 0 |